Yunfan Bai

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

OmniPath: integrated knowledgebase for multi-omics analysis.

OmniPath: integrated knowledgebase for multi-omics analysis.

Journal: Nucleic acids research
Published: August 15, 2025

iTraNet: a web-based platform for integrated trans-omics network visualization and analysis.

iTraNet: a web-based platform for integrated trans-omics network visualization and analysis.

Journal: Bioinformatics advances
Published: June 03, 2024

Time and dose selective glucose metabolism for glucose homeostasis and energy conversion in the liver.

Time and dose selective glucose metabolism for glucose homeostasis and energy conversion in the liver.

Journal: NPJ systems biology and applications
Published: April 20, 2024

Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesity.

Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesity.

Journal: iScience
Published: June 05, 2023

In vivo transomic analyses of glucose-responsive metabolism in skeletal muscle reveal core differences between the healthy and obese states.

In vivo transomic analyses of glucose-responsive metabolism in skeletal muscle reveal core differences between the healthy and obese states.

Journal: Scientific reports
Published: May 13, 2022

Trans-omics analysis of insulin action reveals a cell growth subnetwork which co-regulates anabolic processes.

Trans-omics analysis of insulin action reveals a cell growth subnetwork which co-regulates anabolic processes.

Journal: iScience
Published: January 11, 2022

Trans-omic analysis reveals obesity-associated dysregulation of inter-organ metabolic cycles between the liver and skeletal muscle.

Trans-omic analysis reveals obesity-associated dysregulation of inter-organ metabolic cycles between the liver and skeletal muscle.

Journal: iScience
Published: December 02, 2020

MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation.

MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation.

Journal: OncoTargets and therapy
Published: September 20, 2020

ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.

ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments.

Journal: Journal of cellular and molecular medicine
Published: June 22, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026